Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Schulze-Bergkamen, H
70  Ergebnisse:
Personensuche X
?
1

Correction: Mcl-1 confers protection of Her2-positive breas..:

Bashari, Muhammad Hasan ; Fan, Fengjuan ; Vallet, Sonia...
Breast Cancer Research.  26 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

RELB activation drives tumour aggressiveness and predicts p..:

Nader, Luisa ; Nichetti, Federico ; Scherr, Anna-Lena...
Journal of Hepatology.  77 (2022)  - p. S655-S656 , 2022
Link: https://doi.org/10.1016/..
 
?
3

MCL1 Is Required for Maintenance of Intestinal Homeostasis ..:

Healy, Marc E. ; Boege, Yannick ; Hodder, Michael C....
Gastroenterology.  159 (2020)  1 - p. 183-199 , 2020
Link: https://doi.org/10.1053/..
 
?
4

Identification of BCL-XL as highly active survival factor a..:

Scherr, Anna-Lena ; Mock, Andreas ; Gdynia, Georg...
Cell Death & Disease.  11 (2020)  10 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
5

Knockdown of Atg7 Induces Nuclear-LC3 Dependent Apoptosis a..:

Scherr, Anna-Lena ; Jassowicz, Adam ; Pató, Anna...
International Journal of Molecular Sciences.  21 (2020)  3 - p. 1099 , 2020
Link: https://doi.org/10.3390/..
 
?
6

Identification of BCL-XL as highly active survival factor a..:

Scherr, Anna-Lena ; Mock, Andreas ; Gdynia, Georg...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568722/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
7

A multicentre, phase IIa study of zolbetuximab as a single ..:

Türeci, O. ; Sahin, U. ; Schulze-Bergkamen, H....
Annals of Oncology.  30 (2019)  9 - p. 1487-1495 , 2019
Link: https://doi.org/10.1093/..
 
?
8

Nuclear Translocation of RELB Is Increased in Diseased Huma..:

Elßner, Christin ; Goeppert, Benjamin ; Longerich, Thomas...
Gastroenterology.  156 (2019)  4 - p. 1190-1205.e14 , 2019
Link: https://doi.org/10.1053/..
 
?
9

A multicentre, phase IIa study of zolbetuximab as a single ..:

Türeci, O ; Sahin, U ; Schulze-Bergkamen, H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771222/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
10

A multicentre, phase IIa study of zolbetuximab as a single ..:

Türeci, O ; Sahin, U ; Schulze-Bergkamen, H...
https://mediatum.ub.tum.de/1537964.  , 2019
Link: https://mediatum.ub.tum...
 
?
11

An undifferentiated carcinoma at Klatskin-position with lon..:

Köhler, Bruno Christian ; Goeppert, Benjamin ; Waldburger, Nina...
Oncotarget.  9 (2018)  31 - p. 22230-22235 , 2018
Link: https://doi.org/10.18632..
 
?
12

Rationally derived drug combinations with the novel Mcl-1 i..:

Vallet, Sonia ; Fan, Fengjuan ; Malvestiti, Stefano...
Breast Cancer Research and Treatment.  173 (2018)  3 - p. 585-596 , 2018
Link: https://doi.org/10.1007/..
 
?
13

Phase I study of tomuzotuximab, a glycoengineered therapeut..:

Fiedler, Walter ; Cresta, Sara ; Schulze-Bergkamen, Henning...
ESMO Open.  3 (2018)  2 - p. e000303 , 2018
Link: https://doi.org/10.1136/..
 
?
14

PICCA study: panitumumab in combination with cisplatin/gemc..:

Vogel, Arndt ; Kasper, Stefan ; Bitzer, Michael...
European Journal of Cancer.  92 (2018)  - p. 11-19 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Survival of Hepatocellular Carcinoma Patients Treated with ..:

Apostolidis, Leonidas ; Pfeiffenberger, Jan ; Gotthardt, Daniel...
Gastrointestinal Tumors.  5 (2018)  1-2 - p. 38-46 , 2018
Link: https://doi.org/10.1159/..
 
1-15